|
|
| |
Thursday, 15 March
2018 | Pharma News | Staff Reporter
|
|
|
| |
|
|
| |
Neopharma obtains European
GMP Approval for Abu Dhabi
facility
(Abu Dhabi, UAE) -
The
manufacturing plant was
found to be GMP Compliant as
per the guidelines laid down
by the Directive 2003/94/EC.
The EU – GMP Certification
was accorded to both
manufacturing areas within
Neopharma (General Products,
Beta Lactams).
The approval, which is valid
in the entire European Union
along with other PICS
markets, will facilitate
Neopharma’s entry into
European markets along with
increasing opportunities in
contract manufacturing
business. Neopharma
currently manufactures
general products and Beta –
Lactams in capsules (hard
shelled), tablets and liquid
formulations for internal
use.
The
EU GMP approval comes in
line with Neopharma’s
commitment towards providing
cost effective, high quality
pharmaceutical products. In
addition to the EU – GMP,
the manufacturing facility
at Neopharma is also
compliant as per UAE MOH GMP
guidelines, and ISO
certifications including ISO
9001, ISO 14001 and ISO
180001.
PRINT
THIS ARTICLE
|
|
|
|
|
|
|
|
